摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-ethoxy-5-(4-methoxyphenyl)-4-[2-(4-methoxyphenyl)ethyl]-1H-pyrazole

中文名称
——
中文别名
——
英文名称
3-ethoxy-5-(4-methoxyphenyl)-4-[2-(4-methoxyphenyl)ethyl]-1H-pyrazole
英文别名
——
3-ethoxy-5-(4-methoxyphenyl)-4-[2-(4-methoxyphenyl)ethyl]-1H-pyrazole化学式
CAS
——
化学式
C21H24N2O3
mdl
——
分子量
352.4
InChiKey
IOZRHTIZFQBWER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    26
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    56.4
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • COMPOUNDS FOR TREATING HIV AND METHODS FOR USING THE COMPOUNDS
    申请人:UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    公开号:US20150291534A1
    公开(公告)日:2015-10-15
    Disclosed herein are embodiments of a compound capable of treating HIV. In particular disclosed embodiments, the compound is capable of inhibiting Nef, such as by acting as antagonists of HIV Nef function. Also disclosed are embodiments of a method of making the compound, embodiments of a method of using the compound, and embodiments of a method of identifying HIV Nef antagonists. The disclosed compound may be used alone or in combination with other pharmacologically active agents in order to promote reducing drug resistance and/or cumulative toxicity.
  • US9695127B2
    申请人:——
    公开号:US9695127B2
    公开(公告)日:2017-07-04
  • [EN] COMPOUNDS FOR TREATING HIV AND METHODS FOR USING THE COMPOUNDS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU VIH ET PROCÉDÉS D'UTILISATION DES COMPOSÉS
    申请人:UNIV PITTSBURGH
    公开号:WO2014074628A1
    公开(公告)日:2014-05-15
    Disclosed herein are embodiments of a compound capable of treating HIV. In particular disclosed embodiments, the compound is capable of inhibiting Nef, such as by acting as antagonists of HIV Nef function. Also disclosed are embodiments of a method of making the compound, embodiments of a method of using the compound, and embodiments of a method of identifying HIV Nef antagonists. The disclosed compound may be used alone or in combination with other pharmacologically active agents in order to promote reducing drug resistance and/or cumulative toxicity.
查看更多